Foot DeformitiesNCT06597461
Myofascial Release and Foot Mobility in Basketball Players: A Randomized Controlled Trial
A study testing Myofascial release in people with Foot Deformities, run by Giresun University at 1 site in Turkey (Türkiye).
Trial summary
The purpose of this study was to investigate the acute effects of myofascial release on foot mobility and sportive performance in basketball players with hypomobile feet. This study was designed as randomized controlled experimental research. Read more about this study
- Who is it for?
- Ages 18 to 30 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Foot Deformities
- What is being tested?
- Myofascial release
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 24 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Apr 2024to 17 Jul 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Basketball players who had hypomobility in at least one foot, had not had a serious foot or ankle injury in the last year, and had been actively licensed for the last five years were included in the study.
Who cannot join
- Those who did not meet the inclusion criteria were excluded from the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Acute Effects of Myofascial Release on Foot Mobility and Performance in Basketball Players With Hypomobile feet-a Randomized Controlled Trial
The purpose of this study was to investigate the acute effects of myofascial release on foot mobility and sportive performance in basketball players with hypomobile feet. This study was designed as randomized controlled experimental research.
Read the detailed description
Hypomobility in the foot structure causes functional limitations. These functional limitations affect the sportive performance negatively, especially in basketball where dynamic movements such as jumping and sudden change of direction are very intense. In this context, reducing hypomobility is important in terms of eliminating performance disorders caused by hypomobility. The purpose of this study was to investigate the acute effects of myofascial release on foot mobility and sportive performance in basketball players with hypomobile feet. This study was designed as randomized controlled experimental research. Twenty-four male basketball players (23.46±2.81 years) participated in the study. Athletes were first subjected to foot mobility, balance and vertical jump tests. Then the participants were divided into two groups as myofascial release (MR) and placebo myofascial release (PMR). Myofascial release was applied to the MR group and placebo myofascial release was applied to the PMR group. After the application, foot mobility and performance measurements were performed again and the results were analyzed. It was observed that there was a significant difference in right foot mobility (RFM), left foot mobility (LFM), vertical jump (VJ) and dynamic balance (DB) parameters after the application in MR group (p<0.001), while there was no change in any parameter after the application in PMR group (p>0.05). The results of this study show that a single session of myofascial release applied to the plantar sole temporarily increased foot mobility and improved vertical jump and dynamic balance performance in basketball players with chronic hypomobility.
- Conditions
- Foot Deformities
- Being tested
- Myofascial release, Placebo myofascial release
- Keywords
- hypomobile feet, basketball players, myofascial release, foot mobility, performance
- Medical subject headings
- Foot Deformities
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Myofascial releaseOther
Also called Placebo myofascial release
Graston massage technique was used in the application. In the application, the participant was placed in a prone position and the feet were left slightly outside the massage table. The application was performed on the entire plantar surface between the calcaneal tuberosity and metatarsophalangeal joints in the form of multidirectional strokes at 30-60 degrees with the GT 4 graston tool. The total application took an average of 5 minutes for each foot. An average of 60-70 strokes were performed per minute and 10 seconds of rest was given every minute. The application was performed as a single session by an expert physiotherapist.
Placebo myofascial releaseOther
Graston massage technique was used in the application. In the application, the participant was placed in a prone position and the feet were left slightly outside the massage table. The application was performed on the entire plantar surface between the calcaneal tuberosity and metatarsophalangeal joints in the form of multidirectional strokes at 30-60 degrees with the GT 4 graston tool. The total application took an average of 5 minutes for each foot. An average of 60-70 strokes were performed per minute and 10 seconds of rest was given every minute. The application was performed as a single session by an expert physiotherapist. Since it was a placebo application, no pressure was applied to the tissues by the physiotherapist during the strokes.
| Study group | Role | What they receive |
|---|---|---|
| Myofascial release (MR) group | Active comparator | The group that received Graston myofascial application Receives: Other: Myofascial release |
| Placebo myofascial release (PMR) group | Placebo comparator | The group that received placebo Graston myofascial application Receives: Other: Placebo myofascial release |
What is being measured
The primary outcome is the main question the study is designed to answer.
hypomobility measurement
Therefore, firstly, the degree of foot mobility of all participants was measured, and height and body weight measurements the balance characteristics and vertical jump levels of the participants who met the inclusion criteria were determined. TParticipants were not informed which group they were in. The MR group received myofascial release and the PMR group received placebo (superficial) myofascial release. All myofascial release applications were performed by an expert physiotherapist. After the application, the degree of foot mobility, balance characteristics and vertical jump levels of the participants were measured again. In order to determine the duration of the acute effects of mobility after myofascial release, the MR group was subjected to a 2-hour standard basketball training after the second measurements. Foot mobility was measured three more times at one-hour intervals in the first hour of the training, at the end of the training and then at rest.
Measured: 6 hours
Secondary outcomes (5)
Height and body weight measurements
The height measurements of the participants were measured with wall-mounted holtain stadiometer and body weight and body mass index (BMI) measurements were measured with Tanita MC-580 body analyzer.
Measured: 4 hours
Evaluation of foot mobility
The modified navicular drop (MND) test was used to assess foot mobility. The MND test is an easy, valid and clinical method used in the evaluation of foot mobility. In the navicular drop test, the navicular process was palpated externally while the subject was sitting on a chair with the foot in neutral position and the height above the ground was measured. The subject was then made to stand up and place one foot on a specially designed 10.16 cm (4 inch) high box without weight. The height above the ground of the navicular process of the loaded foot was measured again. Feet with a difference of less than 4 mm between unweighted and weighted measurements were recorded as hypomobile. The reference values of navicular mobility in the MND test are 0-4 mm hypomobile foot, 5-9 mm neutral foot and 10 mm or more hypermobile foot.
Measured: 4 hours
Vertical jump measurements
Vertical jump values were performed with arm swing countermovement jump technique using smart speed brand electronic jump mat. The athlete took a position on the jumping mat with feet one shoulder length apart. Then, when he felt ready, he stretched downward and jumped vertically to the highest point he could jump and fell back on the mat. Three attempts were made in the correct position, 3 seconds rest time was allowed between each jump, and the best degree was recorded in cm. The jumps were repeated with the knees flexed while the athlete remained in the air.
Measured: 4 hours
Determination of balance levels
The balance score was calculated by summing the standard deviation of the front-to-back swing and the standard deviation of the right-to-left swing. The multiaxial proprioceptive assessment module of the isokinetic measurement system was used to determine the dynamic balance levels. First, the device was calibrated and the system was introduced to the volunteers. The volunteers' feet were placed on the platform with reference to the x and y lines on the platform. In the measuring position, the hands were drooping and the feet were bare. Measurements were made in bipedal and 10 difficulty levels for 60 seconds. The test was stopped and restarted when situations such as falling or touching any part of the device occurred during the measurement. Dynamic balance levels were assessed using the average tracking error (ATE).
Measured: 4 hours
Myofascial release application
Graston massage technique was used in the application. In the application, the participant was placed in a prone position and the feet were left slightly outside the massage table. The application was performed on the entire plantar surface between the calcaneal tuberosity and metatarsophalangeal joints in the form of multidirectional strokes at 30-60 degrees with the GT 4 graston tool. The total application took an average of 5 minutes for each foot. An average of 60-70 strokes were performed per minute and 10 seconds of rest was given every minute. The application was performed as a single session by an expert physiotherapist.
Measured: 4 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start15 Apr 2024
- Primary completion15 Jul 2024
- Study completion17 Jul 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Foot DeformitiesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two groups with a control group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- Giresun University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nihat Sarıalioğlu, Giresun University
- Investigators
- Nihat SARIALİOĞLU, PhD, Principal investigator, Giresun University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06597461
- Sponsor's protocol ID
- GRU-SBF-NS-01
- Status last verified
- Sep 2024
- First submitted
- 12 Sep 2024
- Last updated
- 19 Sep 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Acute Effects of Myofascial Release on Foot Mobility and Performance in Basketball Players With Hypomobile feet-a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06597461
- Acronym / sponsor ID
- GRU-SBF-NS-01
- Conditions
- Foot Deformities
- Keywords
- hypomobile feet, basketball players, myofascial release, foot mobility, performance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- Giresun UniversityUniversity, hospital or other
- Study start
- 15 Apr 2024 (actual)
- Primary completion
- 15 Jul 2024 (actual)
- Study completion
- 17 Jul 2024 (actual)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study was to investigate the acute effects of myofascial release on foot mobility and sportive performance in basketball players with hypomobile feet. This study was designed as randomized controlled experimental research.
Detailed description
Hypomobility in the foot structure causes functional limitations. These functional limitations affect the sportive performance negatively, especially in basketball where dynamic movements such as jumping and sudden change of direction are very intense. In this context, reducing hypomobility is important in terms of eliminating performance disorders caused by hypomobility. The purpose of this study was to investigate the acute effects of myofascial release on foot mobility and sportive performance in basketball players with hypomobile feet. This study was designed as randomized controlled experimental research. Twenty-four male basketball players (23.46±2.81 years) participated in the study. Athletes were first subjected to foot mobility, balance and vertical jump tests. Then the participants were divided into two groups as myofascial release (MR) and placebo myofascial release (PMR). Myofascial release was applied to the MR group and placebo myofascial release was applied to the PMR group. After the application, foot mobility and performance measurements were performed again and the results were analyzed. It was observed that there was a significant difference in right foot mobility (RFM), left foot mobility (LFM), vertical jump (VJ) and dynamic balance (DB) parameters after the application in MR group (p<0.001), while there was no change in any parameter after the application in PMR group (p>0.05). The results of this study show that a single session of myofascial release applied to the plantar sole temporarily increased foot mobility and improved vertical jump and dynamic balance performance in basketball players with chronic hypomobility.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Two groups with a control group
| Arm | Type | Receives |
|---|---|---|
| Myofascial release (MR) group | Active comparator | Other: Myofascial releaseThe group that received Graston myofascial application |
| Placebo myofascial release (PMR) group | Placebo comparator | Other: Placebo myofascial releaseThe group that received placebo Graston myofascial application |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Basketball players who had hypomobility in at least one foot, had not had a serious foot or ankle injury in the last year, and had been actively licensed for the last five years were included in the study.
Key exclusion criteria (1 listed)
- Those who did not meet the inclusion criteria were excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Myofascial releaseAlso: Placebo myofascial releaseGraston massage technique was used in the application. In the application, the participant was placed in a prone position and the feet were left slightly outside the massage table. The application was performed on the entire plantar surface between the calcaneal tuberosity and metatarsophalangeal joints in the form of multidirectional strokes at 30-60 degrees with the GT 4 graston tool. The total application took an average of 5 minutes for each foot. An average of 60-70 strokes were performed per minute and 10 seconds of rest was given every minute. The application was performed as a single session by an expert physiotherapist. | Other | Myofascial release (MR) group |
| Placebo myofascial releaseGraston massage technique was used in the application. In the application, the participant was placed in a prone position and the feet were left slightly outside the massage table. The application was performed on the entire plantar surface between the calcaneal tuberosity and metatarsophalangeal joints in the form of multidirectional strokes at 30-60 degrees with the GT 4 graston tool. The total application took an average of 5 minutes for each foot. An average of 60-70 strokes were performed per minute and 10 seconds of rest was given every minute. The application was performed as a single session by an expert physiotherapist. Since it was a placebo application, no pressure was applied to the tissues by the physiotherapist during the strokes. | Other | Placebo myofascial release (PMR) group |
Primary outcome
hypomobility measurement
Time frame: 6 hours
Therefore, firstly, the degree of foot mobility of all participants was measured, and height and body weight measurements the balance characteristics and vertical jump levels of the participants who met the inclusion criteria were determined. TParticipants were not informed which group they were in. The MR group received myofascial release and the PMR group received placebo (superficial) myofascial release. All myofascial release applications were performed by an expert physiotherapist. After the application, the degree of foot mobility, balance characteristics and vertical jump levels of the participants were measured again. In order to determine the duration of the acute effects of mobility after myofascial release, the MR group was subjected to a 2-hour standard basketball training after the second measurements. Foot mobility was measured three more times at one-hour intervals in the first hour of the training, at the end of the training and then at rest.
5 secondary outcomes
Height and body weight measurements
Time frame: 4 hours
Evaluation of foot mobility
Time frame: 4 hours
Vertical jump measurements
Time frame: 4 hours
Determination of balance levels
Time frame: 4 hours
Myofascial release application
Time frame: 4 hour
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
- Individual participant dataSharing planned: No
Related trials for Foot Deformities
Active, not recruitingPhase 2/3
A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Fibrodysplasia Ossificans Progressiva
Recruiting
Effects of Custom 3D Printed Insoles and Short Foot Exercises in Pes Planus
Pes Planus
RecruitingObservational study
A Study of VIRTUGUIDE System and DePuy Synthes Lapidus Implant in Participants Undergoing Lapidus Procedure
Hallux Valgus
Not yet recruitingObservational study
Muscle MRI Fat Fraction Before Surgery to Predict Strength Recovery After Foot-Drop Surgery in Charcot-Marie-Tooth Disease
Foot Drop, Charcot-Marie-Tooth Disease Type 1A
Not yet recruitingPhase 2
Postsurgical Analgesia After Unilateral Bunionectomy
Bunionectomy, Bunion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nihat SARIALİOĞLU, PhD principal investigator
Giresun University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Myofascial release in people with Foot Deformities, run by Giresun University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
hypomobility measurement (time frame: 6 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.